As-Needed Use of Short-Acting β2-Agonists Alone Versus As-Needed Use of Short-acting β2-Agonists Plus Inhaled Corticosteroids in Pediatric Patients With Mild Intermittent (Step 1) Asthma: A Cost-Effectiveness Analysis

Saved in:
Bibliographic Details
Published inPediatrics (Evanston) Vol. 152; no. Supplement 3; pp. S52 - S53
Main Authors Trogen, Brit, Sicherer, Scott
Format Journal Article
LanguageEnglish
Published Evanston American Academy of Pediatrics 01.12.2023
Subjects
Agonists
Asthma
Corticosteroids
Immunomodulators
Pediatrics
Online AccessGet full text
ISSN0031-4005
1098-4275
DOI10.1542/peds.2023-064344NA

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:0031-4005
1098-4275
DOI:10.1542/peds.2023-064344NA